Skip to content

Utah Medical Products UTMD Foreign Income Taxes Ireland

Foreign Income Taxes Ireland at other companies

Willdan Group logo
Willdan GroupWLDN
$4.5K0.0%
Jerash Holdings (US), Inc. logo
Jerash Holdings (US), Inc.JRSH
$109.21K-35.4%
Wrap Technologies logo
Wrap TechnologiesWRAP
$0
Torrid Holdings logo
Torrid HoldingsCURV
$239.5K+4,462%
AstroNova, Inc. logo
AstroNova, Inc.ALOT
$255.5K+568%
LivaNova logo
LivaNovaLIVN
$4.76M+332%

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept fil:ForeignIncomeTaxesIreland.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's foreign income taxes ireland.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's foreign income taxes ireland?
Utah Medical Products (UTMD) reported foreign income taxes ireland of $150.5K in Q4 2025.
How has Utah Medical Products's foreign income taxes ireland changed year-over-year?
Utah Medical Products's foreign income taxes ireland decreased by 81.2% year-over-year, from $802K to $150.5K.
What does foreign income taxes ireland mean?
This metric captures the specific income tax expense incurred by the company's operations within the Irish jurisdiction. It is used to assess the tax implications of the company's international footprint and specific regional tax strategies.